Psoriatic Skin Lesions after Apalutamide Treatment
DOI:
https://doi.org/10.2340/actadv.v102.858Abstract
Abstract is missing (Short communication)
Downloads
References
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, et al. Apalutamide treatment and metastasis-free survival in prostate cancer. N Engl J Med 2018; 378: 1408-1418.
https://doi.org/10.1056/NEJMoa1715546 DOI: https://doi.org/10.1056/NEJMoa1715546
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R et al. Apalutamide for metastatic, castration-sensitive prostate cancer. N Engl J Med 2019; 381: 13-24.
https://doi.org/10.1056/NEJMoa1903307 DOI: https://doi.org/10.1056/NEJMoa1903307
Schwarz W, Schell H, Hornstein OP. Testosterone serum levels in male psoriatics. Arch Dermatol Res 1981; 270: 377-379.
https://doi.org/10.1007/BF00403945 DOI: https://doi.org/10.1007/BF00403945
Cemil BC, Cengiz FP, Atas H, Ozturk G, Canpolat F. Sex hormones in male psoriasis patients and their correlation with the Psoriasis Area and Severity Index. J Dermatol 2015; 42: 500-503.
https://doi.org/10.1111/1346-8138.12803 DOI: https://doi.org/10.1111/1346-8138.12803
Allam JP, Bunzek C, Schnell L, Heltzel M, Weckbecker L, Wilsmann-Theis D et al. Low serum testosterone levels in male psoriasis patients correlate with disease severity. Eur J Dermatol 2019; 29: 375-382.
https://doi.org/10.1684/ejd.2019.3605 DOI: https://doi.org/10.1684/ejd.2019.3605
Rathkopf DE, Scher HI. Apalutamide for the treatment of prostate cancer. Expert Rev Anticancer Ther 2018; 18: 823-836.
https://doi.org/10.1080/14737140.2018.1503954 DOI: https://doi.org/10.1080/14737140.2018.1503954
Shima K, Nomura T, Yamada Y, Usui S, Kobayashi T, Kabashima K. Maculopapular-type drug eruptions caused by apalutamide: case series and a review of the literature. J Eur Acad Dermatol Venereol 2022; 36: e113-e115.
https://doi.org/10.1111/jdv.17657 DOI: https://doi.org/10.1111/jdv.17657
Published
How to Cite
License
Copyright (c) 2022 Fumi Miyagawa, Nobuya Akioka, Noriko Yoshida, Kohei Ogawa, Hideo Asada
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
